FI110667B - Menetelmä farmaseuttisen valmisteen valmistamiseksi - Google Patents

Menetelmä farmaseuttisen valmisteen valmistamiseksi

Info

Publication number
FI110667B
FI110667B FI944961A FI944961A FI110667B FI 110667 B FI110667 B FI 110667B FI 944961 A FI944961 A FI 944961A FI 944961 A FI944961 A FI 944961A FI 110667 B FI110667 B FI 110667B
Authority
FI
Finland
Prior art keywords
chloro
phosphonic acid
enteric coating
treating diseases
methylene bis
Prior art date
Application number
FI944961A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI944961A0 (fi
FI944961L (fi
Inventor
Juhani Posti
Kirsi Katila
Pertti Rantala
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Priority to FI944961A priority Critical patent/FI110667B/fi
Publication of FI944961A0 publication Critical patent/FI944961A0/fi
Publication of FI944961L publication Critical patent/FI944961L/fi
Application granted granted Critical
Publication of FI110667B publication Critical patent/FI110667B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI944961A 1992-04-24 1994-10-21 Menetelmä farmaseuttisen valmisteen valmistamiseksi FI110667B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI944961A FI110667B (fi) 1992-04-24 1994-10-21 Menetelmä farmaseuttisen valmisteen valmistamiseksi

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9201299A SE501389C2 (sv) 1992-04-24 1992-04-24 Farmaceutiskt preparat och förfarande för dess framställning
PCT/FI1993/000166 WO1993021907A1 (en) 1992-04-24 1993-04-21 Pharmaceutical preparation and process for its manufacture
FI944961A FI110667B (fi) 1992-04-24 1994-10-21 Menetelmä farmaseuttisen valmisteen valmistamiseksi

Publications (3)

Publication Number Publication Date
FI944961A0 FI944961A0 (fi) 1994-10-21
FI944961L FI944961L (fi) 1994-10-21
FI110667B true FI110667B (fi) 2003-03-14

Family

ID=20386054

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944961A FI110667B (fi) 1992-04-24 1994-10-21 Menetelmä farmaseuttisen valmisteen valmistamiseksi

Country Status (21)

Country Link
US (1) US5525354A (enExample)
EP (1) EP0637236B1 (enExample)
JP (1) JP3536106B2 (enExample)
AT (1) ATE143802T1 (enExample)
AU (1) AU671830B2 (enExample)
CA (1) CA2134196C (enExample)
CZ (1) CZ282871B6 (enExample)
DE (2) DE637236T1 (enExample)
DK (1) DK0637236T3 (enExample)
EE (1) EE03107B1 (enExample)
ES (1) ES2094539T3 (enExample)
FI (1) FI110667B (enExample)
GR (1) GR3022249T3 (enExample)
HK (1) HK13097A (enExample)
HU (1) HU219342B (enExample)
IL (1) IL105403A (enExample)
NO (1) NO306654B1 (enExample)
RU (1) RU2116074C1 (enExample)
SE (1) SE501389C2 (enExample)
TW (1) TW273515B (enExample)
WO (1) WO1993021907A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
ATE128363T1 (de) * 1993-05-15 1995-10-15 Boehringer Mannheim Gmbh Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff.
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
FI98343C (fi) * 1995-03-21 1997-06-10 Orion Yhtymae Oy Peroraalinen formulaatio
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
JPH11137208A (ja) * 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
EP0998932A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
EP0998933A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
DE60038097T2 (de) * 1999-02-22 2009-02-12 Merrion Research I Ltd. Feste orale dosierungsform enthaltend einen resorptionsverstärker
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
PE20011065A1 (es) 2000-02-01 2001-11-21 Procter & Gamble Proceso para fabricar bisfosfonatos geminales
US6410520B2 (en) 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
WO2002070438A2 (en) * 2001-03-01 2002-09-12 Emisphere Technologies, Inc. Compositions for delivering bisphosphonates
WO2002092616A1 (en) 2001-05-11 2002-11-21 Orasense, Ltd. Antisense permeation enhancers
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
BRPI0710503A2 (pt) 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
US20090280169A1 (en) 2008-05-07 2009-11-12 Merrion Research Iii Limited Compositions of peptides and processes of preparation thereof
WO2011120033A1 (en) 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
AU2012204213A1 (en) 2011-01-07 2013-06-13 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
ES2040733T3 (es) * 1986-12-20 1993-11-01 Boehringer Mannheim Gmbh Medicamentos que contienen clodronato y procedimiento para su preparacion.
EP0313845A1 (en) * 1987-09-29 1989-05-03 Warner-Lambert Company Stabilization of enteric coated dosage form
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique

Also Published As

Publication number Publication date
CA2134196A1 (en) 1993-11-11
CA2134196C (en) 2004-02-10
HK13097A (en) 1997-02-14
EP0637236A1 (en) 1995-02-08
CZ282871B6 (cs) 1997-11-12
EE03107B1 (et) 1998-08-17
SE9201299L (sv) 1993-10-25
GR3022249T3 (en) 1997-04-30
ATE143802T1 (de) 1996-10-15
TW273515B (enExample) 1996-04-01
JPH07505898A (ja) 1995-06-29
NO306654B1 (no) 1999-12-06
SE501389C2 (sv) 1995-01-30
DE69305335D1 (de) 1996-11-14
AU3955093A (en) 1993-11-29
HUT74572A (en) 1997-01-28
NO944001D0 (no) 1994-10-21
AU671830B2 (en) 1996-09-12
CZ261494A3 (en) 1995-02-15
SE9201299D0 (sv) 1992-04-24
NO944001L (no) 1994-10-21
HU219342B (en) 2001-03-28
IL105403A (en) 1998-03-10
RU94045950A (ru) 1996-11-10
DE69305335T2 (de) 1997-04-30
WO1993021907A1 (en) 1993-11-11
JP3536106B2 (ja) 2004-06-07
EP0637236B1 (en) 1996-10-09
ES2094539T3 (es) 1997-01-16
DE637236T1 (de) 1995-07-06
IL105403A0 (en) 1993-08-18
DK0637236T3 (da) 1997-03-17
US5525354A (en) 1996-06-11
RU2116074C1 (ru) 1998-07-27
HU9403067D0 (en) 1994-12-28
FI944961A0 (fi) 1994-10-21
FI944961L (fi) 1994-10-21

Similar Documents

Publication Publication Date Title
FI110667B (fi) Menetelmä farmaseuttisen valmisteen valmistamiseksi
DK0652747T3 (da) Morfinpræparat med reguleret frigivelse
BG104476A (en) Therapeutical form for tolterodin with controlled release
CA2221417A1 (en) Anhydrous alendronate monosodium salt formulations
NZ272608A (en) Inhibiting bone loss by administering a bisphosphonate and a second compound selected from various compounds, including 2-phenyl-3-aroylbenzothienes; bisphosphonate combination salts
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
DE69528525D1 (de) Feuchtgranulierung formulierung für bisphosphonsäuren
CA2200651A1 (en) Sodium alendronate preparation for local administration
FI945593A7 (fi) Rikkipitoisia fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi
KR970705400A (ko) 골 활성 포스포네이트 및 부갑상선 호르몬을 사용한 골다공증의 치료방법(methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone)
SE9303740D0 (sv) Farmaceutisk komposition
AU1753188A (en) Treating agents for renal diseases